Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: Results of cohort 6 of the COSMIC-021 study. Agarwal, N., Loriot, Y., McGregor, B., Dreicer, R., Dorff, T. B., Maughan, B., Kelly, W., Pagliaro, L. C., Srinivas, S., Squillante, C., Vaishampayan, U. N., Wang, E. W., Curran, D., Choueiri, T. K., Pal, S. K. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000560368302407